FEBS Journal

Scope & Guideline

Where Innovation Meets Molecular Insights

Introduction

Welcome to your portal for understanding FEBS Journal, featuring guidelines for its aims and scope. Our guidelines cover trending and emerging topics, identifying the forefront of research. Additionally, we track declining topics, offering insights into areas experiencing reduced scholarly attention. Key highlights include highly cited topics and recently published papers, curated within these guidelines to assist you in navigating influential academic dialogues.
LanguageEnglish
ISSN1742-464x
PublisherWILEY
Support Open AccessNo
CountryUnited Kingdom
TypeJournal
Convergefrom 2005 to 2024
AbbreviationFEBS J / FEBS J.
Frequency24 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
Address111 RIVER ST, HOBOKEN 07030-5774, NJ

Aims and Scopes

The FEBS Journal publishes high-quality research articles that span a wide range of topics in biochemistry, molecular biology, and cellular biology. The journal aims to advance our understanding of biological processes at the molecular level, with a focus on the mechanisms underlying disease and potential therapeutic interventions.
  1. Biochemical and Molecular Mechanisms:
    The journal emphasizes studies that elucidate the biochemical pathways and molecular mechanisms underpinning cellular functions and disease processes, including signaling pathways, metabolic regulation, and enzyme function.
  2. Structural Biology and Biophysics:
    Research involving the structural characterization of biological macromolecules such as proteins and nucleic acids, utilizing techniques like X-ray crystallography, NMR, and cryo-electron microscopy, is a core focus.
  3. Cellular and Developmental Biology:
    The journal covers research on cellular processes, including cell differentiation, growth, and apoptosis, as well as developmental biology, exploring how these processes are regulated at the molecular level.
  4. Cancer Biology and Therapeutics:
    A significant emphasis is placed on studies related to cancer biology, including tumor microenvironment interactions, cancer stem cells, and novel therapeutic strategies.
  5. Immunology and Microbiology:
    The journal publishes articles on immune responses, pathogen-host interactions, and the microbiome's role in health and disease, reflecting the growing interest in these areas.
  6. Neurobiology and Neurodegeneration:
    Research addressing the molecular mechanisms of neurodegenerative diseases, neuroinflammation, and neuronal signaling is prominently featured, highlighting the journal's commitment to understanding brain health.
The FEBS Journal has experienced a notable evolution in its focus areas, with several emerging themes reflecting current scientific trends and societal needs. These trends indicate a shift towards more interdisciplinary and applied research.
  1. Cancer Immunotherapy:
    Publications focusing on cancer immunotherapy have surged, highlighting the importance of understanding immune responses to tumors and the development of novel immunotherapeutic strategies.
  2. Microbiome Research:
    The role of the microbiome in health and disease is increasingly prominent, with studies examining its impact on various physiological processes and its potential as a therapeutic target.
  3. Cellular Senescence and Aging:
    Research on cellular senescence, its role in aging, and its implications for age-related diseases is gaining traction, reflecting a growing interest in understanding the biological mechanisms of aging.
  4. Gene Editing Technologies:
    The application of CRISPR and other gene editing technologies is increasingly featured, focusing on their potential for therapeutic interventions and understanding genetic diseases.
  5. Metabolism and Disease:
    Emerging studies on the links between metabolism, metabolic disorders, and diseases such as cancer and neurodegeneration are becoming more common, emphasizing the importance of metabolic pathways in health.
  6. Extracellular Vesicles:
    Research on extracellular vesicles and their roles in cell communication, disease progression, and potential therapeutic applications is gaining popularity, reflecting their significance in various biological processes.

Declining or Waning

While the FEBS Journal has maintained a broad focus on various aspects of biochemistry and molecular biology, certain themes appear to be declining in prominence over recent years. This may reflect shifts in research priorities or emerging fields of interest.
  1. Basic Enzyme Kinetics:
    Research focusing solely on basic enzyme kinetics has seen a decline, as the field increasingly emphasizes the integration of kinetic studies with structural biology and functional assays.
  2. Traditional Pharmacology:
    There is a noticeable reduction in studies centered on traditional pharmacological approaches, as the focus shifts towards molecular and genetic therapies, particularly in the context of cancer and chronic diseases.
  3. Plant Biochemistry:
    While still relevant, the volume of research specifically addressing plant biochemistry and physiology appears to be waning, potentially due to a shift towards more applied or translational research in agricultural biotechnology.
  4. Studies on Model Organisms:
    Research utilizing model organisms like yeast or Drosophila for basic biological questions is less frequent, with a trend towards more complex systems that reflect human biology more closely.
  5. In Vitro Assays:
    There seems to be a decline in the publication of studies relying solely on in vitro assays without further validation in vivo, as the scientific community increasingly values comprehensive approaches that include physiological relevance.

Similar Journals

BIOCELL

Pioneering Discoveries in Molecular Biology
Publisher: TECH SCIENCE PRESSISSN: 0327-9545Frequency: 12 issues/year

BIOCELL is a distinguished peer-reviewed journal dedicated to the field of Cell Biology, published by TECH SCIENCE PRESS. Since its inception in 1995, the journal has been at the forefront of disseminating innovative research, with converged publication years extending from 1995 to 2013 and from 2015 to 2024. Although it currently holds a Q4 ranking in the Cell Biology category according to the 2023 category quartiles, BIOCELL aims to foster advancements by providing a platform for researchers, professionals, and students to share their findings in biochemistry, genetics, and molecular biology. The journal is available in both print (ISSN: 0327-9545) and digital formats (E-ISSN: 1667-5746) and seeks to attract contributions that enhance scholarly dialogue and understandings of cellular mechanisms and innovations. With a commitment to quality research and critical discourse, BIOCELL plays an important role in nurturing the scientific community within Argentina and beyond, offering vital insights that contribute to the advancement of the life sciences.

CELL PROLIFERATION

Advancing the Frontiers of Cellular Research
Publisher: WILEYISSN: 0960-7722Frequency: 12 issues/year

CELL PROLIFERATION, published by Wiley, is a leading open-access journal that has been at the forefront of research since its inception in 1968. With an impact factor that solidifies its position in the Q1 category of both Cell Biology and Medicine (Miscellaneous), this journal serves as a premier platform for disseminating groundbreaking studies in the field of cellular and molecular biology. The journal is renowned for its rigorous peer-review process and comprehensive coverage of topics related to cell growth, division, and differentiation, making it an invaluable resource for researchers, professionals, and students alike. With its notable Scopus ranking of #30 in Biochemistry, Genetics, and Molecular Biology: Cell Biology, and a robust open access model since 2019, CELL PROLIFERATION ensures that cutting-edge research is accessible to a global audience, fostering collaboration and innovation across the scientific community. Located in the United Kingdom, the journal remains committed to enhancing the understanding of cellular processes, thereby influencing developments in medicine and biotechnology.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Elevating discourse in biochemistry and biophysics.
Publisher: ACADEMIC PRESS INC ELSEVIER SCIENCEISSN: 0006-291XFrequency: 52 issues/year

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, published by Academic Press Inc Elsevier Science, stands as a leading periodical in the fields of biochemistry, biophysics, cell biology, and molecular biology. With an ISSN of 0006-291X and an E-ISSN of 1090-2104, this esteemed journal has been a pivotal platform for the dissemination of groundbreaking research since its inception in 1959, continuing to publish influential findings through at least 2024. It holds a commendable Q2 ranking in Biochemistry and Q1 status in Biophysics as of 2023, reflecting its high impact and relevance in the field, supported by its strong Scopus rankings—ranking #43 in Biophysics and maintaining a presence in the top quartiles of several related categories. Although it is not an open-access journal, it provides critical insights and essential data that cater to researchers, professionals, and students keen on advancing their understanding of complex biochemical and biophysical processes. Its significant contributions to the scientific community underscore the importance of this journal as a reference point for innovative research and collaborative discourse.

CELL DEATH AND DIFFERENTIATION

Connecting Researchers to the Core of Cellular Processes
Publisher: SPRINGERNATUREISSN: 1350-9047Frequency: 12 issues/year

CELL DEATH AND DIFFERENTIATION, published by SpringerNature, is a leading peer-reviewed journal that has been at the forefront of advancing knowledge in the fields of cell biology and molecular biology since its inception in 1994. With an impressive impact factor and ranking in the Q1 quartile for both categories as of 2023, it is recognized as an essential resource for researchers and professionals dedicated to understanding the intricate processes of cellular death and differentiation. The journal publishes high-quality original research articles, reviews, and commentaries, fostering an interdisciplinary dialogue among scientists exploring the molecular mechanisms that underpin these fundamental biological processes. With its commitment to excellence, CEL DEATH AND DIFFERENTIATION bridges gaps in knowledge and stimulates innovation within the scientific community. To access cutting-edge research from this prestigious journal, you may visit their website for subscription options and explore a wealth of knowledge that is crucial for advancing the frontiers of biological research.

CELLULAR & MOLECULAR BIOLOGY LETTERS

Connecting Ideas, Inspiring Innovations in Molecular Biology
Publisher: BMCISSN: 1425-8153Frequency: 1 issue/year

CELLULAR & MOLECULAR BIOLOGY LETTERS, published by BMC, is a premier open-access journal dedicated to disseminating high-quality research in the fields of Biochemistry, Cell Biology, and Molecular Biology. Established in 1996, the journal has emerged as a leader in its domain, boasting an impressive Q1 ranking across three critical categories as of 2023, reflecting its significant impact within the scientific community. With an ISSN of 1425-8153 and an E-ISSN of 1689-1392, it offers accessible research findings to a global audience, having been open access since 2013. Situated in the United Kingdom, at CAMPUS, 4 CRINAN ST, LONDON N1 9XW, the journal continues to serve as a vital resource for researchers, professionals, and students, contributing to advancements in the understanding of cellular and molecular processes. By providing a platform for original research, reviews, and short communications, CELLULAR & MOLECULAR BIOLOGY LETTERS plays a crucial role in fostering dialogue and collaboration within the scientific community.

MOLECULAR AND CELLULAR BIOCHEMISTRY

Unraveling the Mysteries of Molecular Biology
Publisher: SPRINGERISSN: 0300-8177Frequency: 12 issues/year

MOLECULAR AND CELLULAR BIOCHEMISTRY, an esteemed journal published by SPRINGER, serves as a prominent platform in the fields of biochemistry and molecular biology. With a history of dissemination since 1973, this journal has made significant contributions to the understanding of biochemical processes at the molecular level. The MOLECULAR AND CELLULAR BIOCHEMISTRY journal focuses on a myriad of topics including but not limited to cellular biochemistry, clinical biochemistry, and interdisciplinary approaches in medicine, boasting a commendable categorization in the 2023 Scopus ranks where it falls under Q3 in Cell Biology, Q2 in Clinical Biochemistry, Q1 in Medicine (miscellaneous), and Q2 in Molecular Biology. Although the journal is not open access, it provides access options through institutional subscriptions, making valuable research accessible to a wider audience. With its rigorous peer-review process and high impact within the scientific community, this journal aims to advance knowledge and stimulate exploration in biochemical research, making it essential reading for researchers, professionals, and students alike.

Genes & Diseases

Unlocking the secrets of genes to combat diseases.
Publisher: KEAI PUBLISHING LTDISSN: 2352-4820Frequency: 6 issues/year

Genes & Diseases, published by KEAI PUBLISHING LTD, is a premier open-access journal dedicated to advancing the fields of genetics, biochemistry, and molecular biology. Established in 2014 and headquartered in Beijing, China, this journal has quickly risen to prominence, securing a place in the prestigious Q1 quartile in Biochemistry and Genetics (clinical), as well as Q2 in Cell Biology and Q1 in Molecular Biology as of 2023. With a commitment to disseminating cutting-edge research, Genes & Diseases serves as a critical platform for researchers, professionals, and students alike, ensuring that high-quality scientific work is openly accessible to the global community. The journal's exceptional impact is underscored by its selective Scopus rankings, which reflect its influence and relevance in key scientific domains, making it an essential resource for those exploring the intersections of genetics and disease pathology.

JOURNAL OF CELLULAR BIOCHEMISTRY

Unraveling the Complexities of Biochemistry
Publisher: WILEYISSN: 0730-2312Frequency: 12 issues/year

Journal of Cellular Biochemistry is a premier academic journal dedicated to advancing the field of biochemistry and cellular biology. Published by Wiley, this influential journal has a significant impact factor that underscores its relevance and authority within the scientific community. With its ISSN 0730-2312 and E-ISSN 1097-4644, the journal has been on the frontier of research since its inception in 1982, and is expected to continue publishing cutting-edge studies through 2024. As evidenced by its ranking in the 2023 Scopus Quartiles, it holds a rank of Q2 in Biochemistry and Q3 in both Cell and Molecular Biology, placing it among the top tiers of scientific journals in these disciplines. The Journal of Cellular Biochemistry serves as a vital resource for researchers, professionals, and students alike, providing a platform for the dissemination of innovative ideas and findings that shape our understanding of cellular processes and biochemical pathways. Though it does not currently offer Open Access options, its robust peer-review process ensures that each publication meets the highest academic standards, thus solidifying its esteemed position in the landscape of biochemical research.

BIOSCIENCE REPORTS

Driving Progress in Biochemical and Cellular Research
Publisher: PORTLAND PRESS LTDISSN: 0144-8463Frequency: 6 issues/year

BIOSCIENCE REPORTS, published by Portland Press Ltd, is a prestigious journal dedicated to advancing the fields of biochemistry, biophysics, cell biology, and molecular biology. Founded in 1981, the journal has established itself as a vital resource for researchers and professionals, boasting a significant impact factor and high rankings within its categories, including Q2 in Biochemistry and Q1 in Biophysics as of 2023. The journal’s commitment to high-quality, peer-reviewed research ensures that it remains an influential platform for the dissemination of cutting-edge scientific findings. While it operates under a traditional subscription model, it offers various access options to accommodate the needs of the scientific community. With ongoing publication through 2024, BIOSCIENCE REPORTS continues to play a crucial role in shaping discussions in the life sciences and fostering innovative research in biology.

CELL BIOLOGY INTERNATIONAL

Transforming Insights into Cellular Applications
Publisher: WILEYISSN: 1065-6995Frequency: 12 issues/year

CELL BIOLOGY INTERNATIONAL is a prestigious academic journal dedicated to the rapidly evolving field of cell biology, publishing high-quality research aimed at understanding cellular processes and their implications in various biological contexts. Published by Wiley, this journal has established its relevance with an H-Index that reflects its robust citation impact and a commendable Scopus Rank of #111 out of 285 in the field of Biochemistry, Genetics, and Molecular Biology, positioning it in the 61st percentile. Although it operates under a traditional subscription model, its influential insights are crucial for researchers, professionals, and students alike who are seeking cutting-edge developments in cellular mechanisms and their applications in medicine. The journal spans contributions dating back to 1993, providing a rich archive of knowledge that continues to shape the discourse within the scientific community. With a strong category ranking of Q3 in Cell Biology and Q2 in Medicine (miscellaneous) as of 2023, CELL BIOLOGY INTERNATIONAL stands as a reliable platform for disseminating transformative science in the cellular domain.